ANI PHARMACEUTICALS, INC Convertible Notes Payable, Noncurrent
ANI PHARMACEUTICALS, INC (ANIP) had Convertible Notes Payable, Noncurrent of $10.49 million as of 2012-03-31, per its 10-Q filed 2012-05-08.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleLongTermNotesPayable · last filed 2013-02-28
- 2012-03-31: Convertible Notes Payable, Noncurrent $10.49M.
- 2011-12-31: Convertible Notes Payable, Noncurrent $17.34M.
- 2011-09-30: Convertible Notes Payable, Noncurrent $19.24M.
- 2011-06-30: Convertible Notes Payable, Noncurrent $19.75M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2012-03-31 | $10.49M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $17.34M 10-K · filed 2013-02-28 |
| 2011-09-30 | $19.24M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $19.75M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $17.44M 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |